Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Cash from Investing Activities (2016 - 2025)

Neurocrine Biosciences' Cash from Investing Activities history spans 16 years, with the latest figure at -$52.9 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 22.55% year-over-year to -$52.9 million; the TTM value through Dec 2025 reached -$264.4 million, down 108.52%, while the annual FY2025 figure was -$264.4 million, 108.52% down from the prior year.
  • Cash from Investing Activities reached -$52.9 million in Q4 2025 per NBIX's latest filing, up from -$196.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $63.1 million in Q1 2021 to a low of -$201.8 million in Q4 2023.
  • Average Cash from Investing Activities over 5 years is -$58.3 million, with a median of -$54.0 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: surged 134.58% in 2022, then tumbled 896.36% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $23.7 million in 2021, then tumbled by 587.76% to -$115.6 million in 2022, then tumbled by 74.57% to -$201.8 million in 2023, then skyrocketed by 66.15% to -$68.3 million in 2024, then grew by 22.55% to -$52.9 million in 2025.
  • Per Business Quant, the three most recent readings for NBIX's Cash from Investing Activities are -$52.9 million (Q4 2025), -$196.7 million (Q3 2025), and -$29.0 million (Q2 2025).